Track the latest Indaptus Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Indaptus Therapeutics stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
Insiders have report no purchases/sales in the last 30 days.
There has been no Insider buying or selling in the last 90 days.
Aug 16, 2023 | Glen R Anderson | 10% OWNER | 103.35K | $2.09 | $216.39K | BUY | 9.51% | 1.19M | Aug 10 - Aug 14 | View |
Dec 19, 2022 | Boyan Litchev | CHIEF MEDICAL OFFICER | 1.15K | $2.19 | $2.52K | BUY | ∞ | 1.15K | Jan 31 - Dec 01 | View |
Nov 22, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 10.00K | $1.89 | $18.95K | BUY | 15.30% | 75.37K | Nov 18 - Nov 21 | View |
Sep 12, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 10.31K | $2.80 | $28.86K | BUY | 18.72% | 65.37K | Sep 08 | View |
Sep 09, 2022 | Walt Linscott | CHIEF BUSINESS OFFICER | 150.00 | $2.62 | $393.00 | BUY | ∞ | 150.00 | Sep 07 | View |
Sep 08, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 9.69K | $2.56 | $24.77K | BUY | 21.36% | 55.07K | Sep 06 - Sep 07 | View |
Jun 07, 2022 | Jeffrey Meckler | CEO AND DIRECTOR | 19.73K | $2.63 | $51.88K | BUY | 76.92% | 45.37K | Jun 06 | View |
Feb 02, 2022 | Michael Newman | CSO AND DIRECTOR | -20.00K | $5.00 | -$100.04K | SELL | -1.44% | 1.37M | Jan 31 - Feb 01 | View |
Nov 19, 2021 | Jeffrey Meckler | CEO AND DIRECTOR | 11.19K | $5.82 | $65.11K | BUY | 77.37% | 25.65K | Nov 18 | View |
Sep 16, 2021 | Jeffrey Meckler | CEO AND DIRECTOR | 12.00K | $7.00 | $84.00K | BUY | 487.80% | 14.46K | Sep 14 | View |
Browse insider trades on all stocks.